BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17213552)

  • 1. Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
    Lamagni TL; Campbell C; Pezzoli L; Johnson E
    Euro Surveill; 2006 Nov; 11(11):E061116.2. PubMed ID: 17213552
    [No Abstract]   [Full Text] [Related]  

  • 2. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    Chamilos G; Kontoyiannis DP
    J Infect; 2005 Nov; 51(4):e225-8. PubMed ID: 16291275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Paecilomyces variotii in clinical samples and settings.
    Houbraken J; Verweij PE; Rijs AJ; Borman AM; Samson RA
    J Clin Microbiol; 2010 Aug; 48(8):2754-61. PubMed ID: 20519470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three cases of fungemia caused by Blastoschizomyces capitatus].
    Koç AN; Copur Çiçek A; Kaynar L; Sav H; Kasap Tekinşen FF; Atalay MA
    Mikrobiyol Bul; 2013 Oct; 47(4):734-41. PubMed ID: 24237444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility testing and molecular classification of Paecilomyces spp.
    Castelli MV; Alastruey-Izquierdo A; Cuesta I; Monzon A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2926-8. PubMed ID: 18519716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.
    Bellanger AP; Cervoni JP; Faucher JF; Weil-Verhoeven D; Ginet M; Deconinck E; Grenouillet F
    Mycopathologia; 2017 Aug; 182(7-8):761-765. PubMed ID: 28365835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
    Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
    Steinbach WJ; Singh N; Miller JL; Benjamin DK; Schell WA; Heitman J; Perfect JR
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4922-5. PubMed ID: 15561883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
    Shuford JA; Piper KE; Steckelberg JM; Patel R
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: caspofungin acetate for treatment of invasive fungal infections.
    Chan J
    Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
    Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
    J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.